Trials / Withdrawn
WithdrawnNCT05045092
A Follow-up Study of Neonates Receiving Extracorporeal Life Support in China
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Children's Hospital of Fudan University · Academic / Other
- Sex
- All
- Age
- 1 Hour – 1 Month
- Healthy volunteers
- Not accepted
Summary
Descriptive study of two-year follow-up outcomes of surviving neonates who are enrolled in the Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS) from 2022 to 2024.
Detailed description
This study aims to describe the six -month, one-year and two-year neurodevelopmental outcomes of survivors of neonatal ECLS treatment in the Chi-NELS. The study population will be neonates who receive ECLS support within 28 days of life and are enrolled in the Chi-NELS. These infants will be prospectively followed for two years. Mortality, growth, and neurodevelopmental outcomes will be assessed at six months, one year and two years.
Conditions
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2021-09-16
- Last updated
- 2024-01-16
Source: ClinicalTrials.gov record NCT05045092. Inclusion in this directory is not an endorsement.